Results 31 to 40 of about 1,162 (153)
Neuromuscular blockade management for intraoperative neural monitoring
Kaohsiung Journal of Medical Sciences, 2020 This article reviews the literature on development of neuromuscular blockade management in thyroid surgery with intraoperative neural monitoring (IONM) in the past decade.
I‐Cheng Lu +2 more
doaj +1 more source
European Journal of Neurology, Volume 29, Issue 12, Page 3486-3507, December 2022., 2022 This consensus statement summarizes the most important recommendations concerning anaesthesia in patients with neuromuscular disorders. Abstract Background and purpose Patients with neuromuscular conditions are at increased risk of suffering perioperative complications related to anaesthesia.
Luuk R. van den Bersselaar +21 more
wiley +1 more source
Pediatric Anesthesia, Volume 32, Issue 8, Page 916-925, August 2022., 2022 Abstract Background The prevalence and risk factors for residual neuromuscular blockade in children remain poorly characterized. We hypothesize that specific patient and anesthetic risk factors may be associated with the administration of additional reversal in children following initial reversal of rocuronium with neostigmine.
Susan R. Vishneski +8 more
wiley +1 more source
Ain Shams Journal of Anesthesiology, 2023 Background There are many methods used for cranial nerve monitoring in cerebellopontine angle (CPA) tumor excision with or without muscle relaxant which may affect hemodynamics and consumption of drug doses.
Safinaz H. Osman +4 more
doaj +1 more source
Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis
Annals of Clinical and Translational Neurology, Volume 9, Issue 6, Page 786-794, June 2022., 2022 Abstract Background Primary focal hyperhidrosis (PFH) is an autonomic neurological disease in which exocrine glands are oversecreted due to autonomic dysfunction of the sympathetic nervous system. Chrna1 promotes the pathogenesis of PFH. We aimed to check if downregulating of Chrna1 by cisatracurium could alleviate the symptoms of PFH.
Jian‐Bo Lin +3 more
wiley +1 more source
Rocuronium-Sugammadex in Anesthesia for Electroconvulsive Therapy [PDF]
Psikiyatride Güncel Yaklaşımlar, 2016 Electroconvulsive therapy (ECT) is a form of treatment which is very effective in many psychiatric disorders. The administration of anesthesia plays a positive role in the success of ECT and improves the oxygenation of the body during the process ...
Nilay Tas, Esra Yancar Demir
doaj +1 more source
The effect of intravenous paracetamol for the prevention of rocuronium injection pain
Kaohsiung Journal of Medical Sciences, 2014 Rocuronium is a nondepolarizing neuromuscular blocking agent used in anesthesia induction and is associated with considerable discomfort and burning pain during injection, which is reported to occur in 50–80% of patients.
Sennur Uzun +3 more
doaj +1 more source
, 2023 Anaesthesia Reports, Volume 11, Issue 2, July‐December 2023.
K. Farkas +5 more
wiley +1 more source
The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade [PDF]
Korean Journal of Anesthesiology, 2013 BackgroundGentamicin reduces acetylcholine release and clindamycin causes end-plate ion channel blockade. Because of these reasons, two drugs show muscular relaxant effect and potentiate the action of nondepolarizing neuromuscular agents.
Ji Hyeon Lee +7 more
doaj +1 more source
New‐Onset Myasthenia Gravis Mimics Spinal Cord Injury After Zenker's Diverticulum Repair
, 2023 OTO Open, Volume 7, Issue 2, April–June 2023.
Steffen E. Meiler +2 more
wiley +1 more source